Risk prediction for hypertension, elevated plasma triglyceride and metabolic syndrome
Docket Number:12A-930506
Inventor:Wen-Harn Pan, Yuh-Shan Jou, Jaw-Wen Chen, Cathy-S-J Fann
IP Status:Issued TWI357445
Abstract:
Metabolic syndrome is characterized by a constellation of disorders: namely hypertension, hypertriglyceridemia, hyperglycemia, abdominal obesity and low HDL-C. This syndrome is affecting the health of a great proportion of people in the world. Asian, including Chinese, is particularly susceptible to it. We discovered that a common LPL haplotype is associated with hypertension, hypertriglyceridemia, and metabolic syndrome.
Fields of Application:
Screening, pharmacogenetics, and treatment of hypertension, hypertriglyceridemia, and metabolic syndrome.
Advantages when compared to the existing technologies:
The LPL haplotype we identified is a common genetic variant which affects sizable proportion of the population.
Contact Person:Mei-Fang Lee / 886-2-2787-2503 / mflee@gate.sinica.edu.tw
IP Status:Issued TWI357445
